Levocetirizine Dihydrochloride 43598-0735-04
- Manufacturer
- Dr. Reddy's Laboratories Inc.
- Dosage Form
- Tablet, Coated
- Route
- Oral
- Product Type
- Human Otc Drug
- Marketing Start
- March 12, 2018
- Listing Expires
- December 31, 2026
- Application
- ANDA210375
Active Ingredients
| Ingredient | Strength |
|---|---|
| Levocetirizine Dihydrochloride | 5 mg/1 |
Drug Class
Histamine H1 Receptor Antagonists [MoA]Histamine-1 Receptor Antagonist [EPC]
Selected Package
43598-0735-04Selected1 BOTTLE in 1 CARTON (43598-735-04) / 120 TABLET, COATED in 1 BOTTLE
Other packages for this product(8)
1 BOTTLE in 1 CARTON (43598-735-22) / 55 TABLET, COATED in 1 BOTTLE
1 BOTTLE in 1 CARTON (43598-735-30) / 30 TABLET, COATED in 1 BOTTLE
1 BOTTLE in 1 CARTON (43598-735-35) / 35 TABLET, COATED in 1 BOTTLE
1 BOTTLE in 1 CARTON (43598-735-58) / 10 TABLET, COATED in 1 BOTTLE
2 BLISTER PACK in 1 CARTON (43598-735-79) / 5 TABLET, COATED in 1 BLISTER PACK
1 BOTTLE in 1 CARTON (43598-735-80) / 80 TABLET, COATED in 1 BOTTLE
1 BOTTLE in 1 CARTON (43598-735-90) / 90 TABLET, COATED in 1 BOTTLE
2 BOTTLE in 1 CARTON (43598-735-95) / 200 TABLET, COATED in 1 BOTTLE